MPO and atrial fibrillation: Mpo−/− mice showed markedly reduced atrial fibrosis and were almost completely protected from the increased vulnerability to atrial fibrillation caused by AngII administration, and both of these effects were dose‐dependently reversed upon restitution of MPO.2